These data thus suggested that phosphorylation of MET, EGFR, HER2, HER3, and RET as well as that of the downstream signalling molecules is dependent on the kinase activity of MET, but is independent of that of the other RTKs, in MET amplification-positive lung cancer cells. Here, ERBB3 is linked to lung carcinoma.